HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Five-Year Follow-Up and Outcomes of Noninvasive Ventilation in Subjects With Neuromuscular Diseases.

AbstractINTRODUCTION:
The purpose of this study was to investigate the 5-year outcomes of noninvasive ventilation (NIV) application in different neuromuscular disease (NMD) groups.
METHODS:
We categorized 180 subjects who had initiated NIV between March 2001 and August 2009 into 4 groups and followed them for > 5 y. The NIV maintenance rate and average duration, applying time, and forced vital capacity (FVC) were investigated at the time NIV was initiated and 5 y after NIV initiation in each group.
RESULTS:
In subjects with amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), and spinal muscular atrophy (SMA)-congenital myopathy, the 5-year subjects who continued to use NIV over time were 22.5%, 89.4%, and 91.3%, respectively, and the average NIV maintenance durations were 21.53 ± 19.26 months, 55.22 ± 11.47 months, and 57.48 ± 8.34 months, respectively (P < .001). Median daily applying time changed from 8.0 h to 24.0 h (P < .001), from 8.0 h to 12.0 h (P < .001), and from 8.0 h to 9.0 h (P = .11) in subjects with ALS, DMD, and SMA-congenital myopathy, respectively. FVC decreased significantly after 5 y except in the group with combined SMA-congenital myopathy.
CONCLUSIONS:
NIV was tolerated long-term without significant increases in daily application time for most subjects with NMD. However, in individuals with ALS, development of severe bulbar symptoms can risk maintaining NIV.
AuthorsMi Ri Suh, Won Ah Choi, Dong Hyun Kim, Jang Woo Lee, Eun Young Kim, Seong-Woong Kang
JournalRespiratory care (Respir Care) Vol. 63 Issue 3 Pg. 274-281 (Mar 2018) ISSN: 1943-3654 [Electronic] United States
PMID29298901 (Publication Type: Journal Article)
CopyrightCopyright © 2018 by Daedalus Enterprises.
Topics
  • Adolescent
  • Adult
  • Aged
  • Amyotrophic Lateral Sclerosis (complications, physiopathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Muscular Atrophy, Spinal (complications, congenital, physiopathology)
  • Muscular Dystrophy, Duchenne (complications, physiopathology)
  • Noninvasive Ventilation
  • Respiratory Insufficiency (etiology, physiopathology, therapy)
  • Survival Rate
  • Time Factors
  • Tracheostomy
  • Vital Capacity
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: